Rohto Pharmaceutical Co(JP:4527)
Â¥2,762.00+-18.00 (+2.45%)
JP:4527
Rohto Pharmaceutical Co Revenue
Â¥2,762.00
At close:+-18.00 (+2.45%)
Want to see JP:4527 full AI Analyst Report?
Rohto Pharmaceutical Co (4527) Revenue
2 Followers
Rohto Pharmaceutical Co Revenue
Rohto Pharmaceutical Co had a revenue of 91.62B in the quarter ending Jun 30, 2026, with 1.07%. This bring the company's revenue in the last twelve months to 353.38B, Increased 2.81%. In the fiscal year ending Mar 31, 2026, Rohto Pharmaceutical Co had annual revenue of 343.73B with 11.37% growth.
- Revenue (ttm)
- 353.38B
- Revenue Growth
- 9.67%
- P/S Ratio
- 1.87
- Revenue/Employee
- JPY 36,991,498
- Employees
- 9,292
- Market Cap
- JPY 641.22B
Revenue Chart
Rohto Pharmaceutical Co Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 343.73B | 35.10B | 11.37% |
| Mar 31, 2026 | 308.63B | 37.78B | 13.95% |
| Mar 31, 2025 | 270.84B | 32.18B | 13.48% |
| Mar 31, 2024 | 238.66B | 39.02B | 19.54% |
| Mar 31, 2023 | 199.65B | 18.59B | 10.27% |
| Mar 31, 2022 | 181.05B | -7.32B | -3.89% |
| Mar 31, 2021 | 188.38B | 4.70B | 2.56% |
| Mar 31, 2020 | 183.67B | 11.88B | 6.91% |
| Mar 31, 2019 | 171.79B | 17.20B | 11.12% |
| Mar 31, 2017 | 154.60B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.